Drug Delivery

In today's healthcare industry, drug delivery companies have become key partners in product development. New innovative technologies that include fully resorbable polymers allow for increased performance of new and existing pharmaceutical compounds. Ultimately the patients will benefit from the enhanced efficacy of pharmaceutical products and minimized side effects through controlled local delivery of (bio)therapeutics.

InnoCore develops and manufactures drug delivery products that allow the controlled release of a wide range of small to medium sized drug molecules, including peptide-based therapeutics. These formulations are based on resorbable polymers, developed using the company's proprietary SynBiosys technology. Depending on the drug type, required drug loading,  release period and site of application, SynBiosys polymers can be processed into injectable depot formulations such as controlled release microspheres or rod-type solid implants, drug eluting medical device coatings and surgically implantable drug-eluting films, membranes or scaffolds. The versatility of SynBiosys polymers ensures formulations that are specifically geared towards the needs of our customers.

Examples of product and application areas of SynBiosys^TM formulations are:

• Drug eluting coatings: Cardiology (vascular stents, vascular grafts, catheter systems, heart valves); Orthopedics (implants / prostheses); Urology (stents, catheters), etc.  Read More >> 
  
  
• Injectable microspheres: Oncology (drug loaded microspheres); Pain management; Arthritis; CNS (Parkinson, Schizophrenia), etc. Read More >>
  
  
• Injectable solid implants: Oncology (drug eluting mini rods); Contraception; Dental applications; Ophthalmology,  etc. Read More >>